XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Debt Obligations - 2027 Term Loan - Narrative (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2022
USD ($)
Jan. 31, 2022
USD ($)
item
Mar. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
Jan. 05, 2022
USD ($)
tranche
Apr. 30, 2020
USD ($)
Feb. 29, 2016
USD ($)
Debt Instrument [Line Items]              
Outstanding amount paid off       $ 81,750      
Outstanding amount payoff       109,000      
2027 Term Loans | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount         $ 300,000    
Number of tranches | tranche         4    
Net carrying value       196,037      
Stated interest rate   8.25%          
Quarterly payments | item   5          
Loan agreement covenants, minimum trailing twelve month net sales for current quarter   $ 200,000          
Loan agreement covenants, minimum trailing twelve month net sales for the quarter ended March 30, 2024   210,000          
Loan agreement covenants, minimum trailing twelve-month net sales for the quarter ended June 30, 2024   230,000          
Loan agreement covenants, minimum trailing twelve-month net sales for the quarter ended September 30, 2024   270,000          
Loan agreement covenants, minimum trailing twelve-month net sales for the quarter ended December 31, 2024 and thereafter   $ 300,000          
Mandatory prepayment term   10 days          
Debt discounts and issuance costs   $ 6,800          
Remaining unamortized debt discount and debt offering costs       $ 3,963      
Effective interest rate       9.25%      
2027 Term Loans | BioPharma Credit Investments V GP LLC | Three-month LIBOR              
Debt Instrument [Line Items]              
Spread on variable rate   1.00%          
2027 Term Loans | Additional facility amount | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount   $ 100,000          
Tranche A Loan, funded January 5, 2022 | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount         $ 100,000    
Debt discounts and issuance costs   7,800          
Tranche B Loan, funded no later than April 1, 2022 | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount $ 100,000   $ 100,000        
Debt discounts and issuance costs     2,300        
Convertible notes, Issuance Cost $ 1,000   $ 1,000        
Tranche C Loan, funded between April 1, 2022 and March 17, 2023 | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount   50,000          
Tranche D Loan, funded between April 1, 2022 and March 17, 2023 | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Principal amount   50,000          
1.5% Convertible Senior Subordinated Notes due 2026 | Convertible Notes              
Debt Instrument [Line Items]              
Principal amount           $ 230,000  
Net carrying value       $ 224,928      
Stated interest rate           1.50%  
Remaining unamortized debt discount and debt offering costs       $ 5,072      
Effective interest rate       2.10%      
1.5% Convertible Senior Subordinated Notes due 2026 | BioPharma Credit Investments V GP LLC | Scenario, Plan | Minimum              
Debt Instrument [Line Items]              
Principal amount   50,000          
8.2% Convertible Notes due 2022 | Convertible Notes              
Debt Instrument [Line Items]              
Principal amount   100,000         $ 100,000
Stated interest rate 8.20%   8.20%       8.20%
Outstanding amount payoff $ 111,100 111,100          
2025 Term Loan              
Debt Instrument [Line Items]              
Net carrying value       $ 0      
2025 Term Loan | Convertible Notes              
Debt Instrument [Line Items]              
Principal amount   75,000          
Outstanding amount paid off   $ 81,900          
Tranche A and B Loans | BioPharma Credit Investments V GP LLC              
Debt Instrument [Line Items]              
Remaining unamortized debt discount and debt offering costs       $ 4,000      
Remaining term       4 years 6 months